Managers' transactions, 10 June 2022 at 08:50 (EEST)

____________________________________________

Person subject to the notification requirement

Name: Soininen, Timo

Position: Member of the Board/Deputy member

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 16035/6/4

____________________________________________

Transaction date: 2022-06-08

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 33 Unit price: 1.9900 EUR

(2): Volume: 1,952 Unit price: 1.9900 EUR

(3): Volume: 144 Unit price: 2.0000 EUR

(4): Volume: 2,000 Unit price: 1.9780 EUR

(5): Volume: 628 Unit price: 1.9700 EUR

(6): Volume: 3.000 Unit price:  1.9780 EUR

(7): Volume: 1,365 Unit price: 1.9760 EUR

(8): Volume: 2,611 Unit price: 1.9780 EUR

(9): Volume: 1,000 Unit price: 1.9780 EUR

(10): Volume: 368 Unit price: 1.9620 EUR

(11): Volume: 568 Unit price: 1.9780 EUR

(12): Volume: 552 Unit price: 1.9780 EUR

(13): Volume: 74 Unit price: 1.9500 EUR

(14): Volume: 45 Unit price: 1.9500 EUR

(15): Volume: 99 Unit price: 1.9500 EUR

(16): Volume: 13 Unit price: 1.9920 EUR

(17): Volume: 1,392 Unit price: 1.9920 EUR

(18): Volume: 198 Unit price: 1.9920 EUR

(19): Volume: 448 Unit price: 1.9650 EUR

(20): Volume: 421 Unit price: 2.000 EUR

(21): Volume: 322 Unit price: 1.9970 EUR

(22): Volume: 901 Unit price: 2.000 EUR

(23): Volume: 3,178 Unit price: 2.0300 EUR

(24): Volume: 564 Unit price: 2.0300 EUR

(25): Volume: 94 Unit price: 2.0300 EUR

(26): Volume: 438 Unit price: 2.0225 EUR

(27): Volume: 232 Unit price: 2.0350 EUR

(28): Volume: 541 Unit price: 2.0350 EUR

(29): Volume: 500 Unit price: 2.0350 EUR

(30): Volume: 739 Unit price: 2.0350 EUR

(31): Volume: 580 Unit price: 2.0350 EUR

Aggregated transactions

(31): Volume: 25,000 Volume weighted average price: 1.99503 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com

Certified Adviser:
Oaklins Merasco Ltd. tel. +358 9 6129 670

About Nightingale Health

Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it's also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.